title: Cost analysis of radiofrequency catheter ablation for atrial fibrillation.
abstract: Atrial fibrillation is the most common arrhythmia associated with increased mortality and morbidity. Its management requires high healthcare expenditures; 52%-70% of expenses for AF care are constituted by hospitalization costs. The current management strategies of pharmacological rhythm control and pharmacological or invasive rate control show no difference in impact on major outcomes in patients with AF. Radiofrequency catheter ablation (RFA) has been shown to reduce the risk of AF recurrence, improve quality of life and reduce hospitalization rate as compared to pharmacological rhythm control and rate control strategies. This review summarizes current knowledge on cost and cost-effectiveness analysis of RFA for patients with atrial fibrillation.
authors: Department of Cardiology, Faculty of Medicine, Osmangazi Eskisehir University, Eskisehir, Turkey. bulent@gorenek.com
authors: Bulent
authors: B
authors: Gorenek
authors: Gulmira
authors: G
authors: Kudaiberdieva
mesh_terms: D000818:Animals; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000191:economics* / Q000601:surgery*; D017115:Catheter Ablation / Q000191:economics* / Q000379:methods; D003365:Costs and Cost Analysis / Q000191:economics / Q000379:methods; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000191:economics / Q000379:methods
keywords: Atrial fibrillation; Cost analysis; Cost-effectiveness analysis; Outcomes; Radiofrequency catheter ablation